Literature DB >> 265522

Nerve growth factor receptors on human melanoma cells in culture.

R N Fabricant, J E De Larco, G J Todaro.   

Abstract

Purified mouse nerve growth factor (NGF)radiolabeled with 125I was tested for its ability to bind to a variety of different cultured cells. NGF binds readily to human and hamster melanoma cells but does not bind to many other cell lines. The three cell lines with the highest number of NGF receptors were derived from metastatic melanomas. One of these lines, A875, was studied in detail and was shown to have approximately 7x10(5) NGF receptors per cell with an association constant of 1.0x10(9) liters/mole. The use of these cells in competition binding assays permits the detection of 0.25 ng of NGF in various biologic fluids. NGF can be shown to increase the survival, but not the division, of melanoma cells maintained in medium depleted of serum growth factors. This effect of NGF as a specific "survival factor" appears analogous to its effect on cultured sympathetic ganglion cells and on other cells derived from the neural crest.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 265522      PMCID: PMC392331          DOI: 10.1073/pnas.74.2.565

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

Authors:  F C GREENWOOD; W M HUNTER; J S GLOVER
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

2.  Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal.

Authors:  S COHEN
Journal:  J Biol Chem       Date:  1962-05       Impact factor: 5.157

3.  In vitro experiments on the effects of mouse sarcomas 180 and 37 on the spinal and sympathetic ganglia of the chick embryo.

Authors:  R LEVI-MONTALCINI; H MEYER; V HAMBURGER
Journal:  Cancer Res       Date:  1954-01       Impact factor: 12.701

4.  Continuous culture of a melanotic cell line from the golden hamster.

Authors:  G E MOORE; D F LEHNER; Y KIKUCHI; L A LESS
Journal:  Science       Date:  1962-09-21       Impact factor: 47.728

5.  Epidermal growth factor: receptors in human fibroblasts and modulation of action by cholera toxin.

Authors:  M D Hollenberg; P Cuatrecasas
Journal:  Proc Natl Acad Sci U S A       Date:  1973-10       Impact factor: 11.205

6.  Induction of cell division in medium lacking serum growth factor by SV40.

Authors:  H S Smith; C D Scher; G J Todaro
Journal:  Virology       Date:  1971-05       Impact factor: 3.616

7.  Synthesis of nerve growth factor by L and 3T3 cells in culture.

Authors:  J Oger; B G Arnason; N Pantazis; J Lehrich; M Young
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

8.  Increased nerve-growth-factor beta-chain cross-reacting material in familial dysautonomia.

Authors:  D C Siggers; J G Rogers; S H Boyer; L Margolet; H Dorkin; S P Banerjee; E M Shooter
Journal:  N Engl J Med       Date:  1976-09-16       Impact factor: 91.245

9.  Transformation by murine and feline sarcoma viruses specifically blocks binding of epidermal growth factor to cells.

Authors:  G J Todaro; J E De Larco; S Cohen
Journal:  Nature       Date:  1976-11-04       Impact factor: 49.962

10.  Specific binding of nerve growth factor (NGF) by murine C 1300 neuroblastoma cells.

Authors:  R Revoltella; L Bertolini; M Pediconi; E Vigneti
Journal:  J Exp Med       Date:  1974-08-01       Impact factor: 14.307

View more
  174 in total

1.  Mutations in the human homologue of the Drosophila segment polarity gene patched in oral squamous cell carcinoma cell lines.

Authors:  E Michimukai; N Kitamura; Y Zhang; H Wang; Y Hiraishi; K Sumi; Y Hayashido; S Toratani; T Okamoto
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001 Jul-Aug       Impact factor: 2.416

Review 2.  Monoclonal antibodies to epidermal growth factor receptors in studies of receptor structure and function.

Authors:  T Kawamoto; G H Sato; K Takahashi; M Nishi; S Taniguchi; J D Sato
Journal:  Cytotechnology       Date:  1990-05       Impact factor: 2.058

3.  Activity of the epidermal-growth-factor receptor and phospholipase C-gamma 1 in heat-stressed fibroblasts and A-431 cells.

Authors:  S M Liu; G Carpenter
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

4.  Growth of the malignant and nonmalignant human squamous cells in a protein-free defined medium.

Authors:  K Rikimaru; H Toda; N Tachikawa; N Kamata; S Enomoto
Journal:  In Vitro Cell Dev Biol       Date:  1990-09

5.  Wnt directs the endosomal flux of LDL-derived cholesterol and lipid droplet homeostasis.

Authors:  Cameron C Scott; Stefania Vossio; Fabrizio Vacca; Berend Snijder; Jorge Larios; Olivier Schaad; Nicolas Guex; Dmitry Kuznetsov; Olivier Martin; Marc Chambon; Gerardo Turcatti; Lucas Pelkmans; Jean Gruenberg
Journal:  EMBO Rep       Date:  2015-04-07       Impact factor: 8.807

6.  Identification of a truncated form of the nerve growth factor receptor.

Authors:  P S DiStefano; E M Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

Review 7.  Identification of tyrosine kinase Trk as a nerve growth factor receptor.

Authors:  A H Ross
Journal:  Cell Regul       Date:  1991-09

8.  Molecular cloning and in vitro expression of a cDNA clone for human cellular tumor antigen p53.

Authors:  E Harlow; N M Williamson; R Ralston; D M Helfman; T E Adams
Journal:  Mol Cell Biol       Date:  1985-07       Impact factor: 4.272

9.  Precise mapping of the EGF receptor gene on the human chromosome 7p12 using an improved fish technique.

Authors:  Y Wang; S Minoshima; N Shimizu
Journal:  Jpn J Hum Genet       Date:  1993-12

10.  A t-butyloxycarbonyl-modified Wnt5a-derived hexapeptide functions as a potent antagonist of Wnt5a-dependent melanoma cell invasion.

Authors:  Veronika Jenei; Victoria Sherwood; Jillian Howlin; Rickard Linnskog; Annette Säfholm; Lena Axelsson; Tommy Andersson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.